EMIT: Targeted Radio Therapy
Overcoming the technical, regulatory and clinical challenges in targeted radio therapy
30 – 31 January 2013
Washington, D.C.
ISOTOP-4-LIFE
ISOTOP-4-LIFE is a French consortium which aims to mutualise and structure resources around radioisotopes for health in order to lift constraints to innovation in the domain of radiopharmaceuticals dedicated mainly to oncology. Its ambitions with its first members as Arronax, Chelatec, Atlab, Ico/Chu, Keosys, Lemer Pax… is to: Facilitate evaluation of biotherapeutics, Facilitate R&D of Radio Immuno Conjugates, Facilitate the transfer to patient, Facilitate personalized medicine: right patient/right time/right dose/right treatment, Facilitate production & distribution of radiopharmaceutical drugs for patient benefits, Optimise quality and safety and Optimise radiation protection.
Contact: jfgestin@chelatec.fr